CDC: More Data Needed Before Decision On Johnson & Johnson Vaccine

The CDC advisory committee says more data on rare blood clots needs to be done before deciding on the next steps of the Johnson & Johnson COVID vaccine.

Video Transcript

- To some breaking news here in our newsroom now. The CDC advisory committee says more data on rare blood clots needs to be done before deciding next steps of the J&J vaccine. The committee was discussing the pause on this vaccine suggested by the FDA. They will now reconvene in a week to 10 days to re-evaluate.